Skip to main content
Top
Published in: Journal of Cancer Research and Clinical Oncology 9/2012

01-09-2012 | Original Paper

A potential probe set of fluorescence in situ hybridization for detection of lung cancer in bronchial brushing specimens

Authors: Yi-Zhen Liu, Zhen Wang, Li-Li Fang, Lu Li, Jian Cao, Xin Xu, Ya-Ling Han, Yan Cai, Liang-Xu Wang, Ming-Rong Wang

Published in: Journal of Cancer Research and Clinical Oncology | Issue 9/2012

Login to get access

Abstract

Purpose

The study aims to find candidate probes of fluorescence in situ hybridization (FISH) for detection of lung cancer with bronchial brushings and to evaluate whether the accuracy of diagnosing lung cancer by cytological deviant and genetic abnormalities is greater than that of cytology alone.

Methods

Centromeric enumeration probes (CEPs) for chromosomes 2, 3, 6, 7, 8, 9, 11, 12, and 17 were analyzed using FISH in 74 surgical resection tissues, 32 operative margin tissues without tumor involvement of lung cancer, and 174 bronchial brushings.

Results

The aneuploidy rates of the tested probes were 61.7, 89.1, 80.0, 92.7, 65.0, 70.4, 66.7, 71.8, 68.9 % in tumor tissues, and 29.3, 58.9, 33.3, 69.6, 67.0, 40.3, 38.0, 49.3, 35.1 % in bronchial brushings. The combination of cytology and FISH using the three-probe set for chromosomes 3+7+8 significantly improved the sensitivity of bronchial brushing examination for lung cancer detection (P = 0.00003), especially squamous cell carcinoma (SCC), which increased from 78.0 to 98.2 %. The specificity of the 3+7+8 probe set was 94.6 %. Moreover, a high aneuploidy rate of the probe set in bronchial brushings was detected more often in SCCs (P = 0.029) and late-stage non-small-cell lung cancer (NSCLC) (P = 0.044). Kaplan–Meier curves indicated that adenocarcinoma (ADC) patients with high aneuploidy rate of CEP3 in tissue samples exhibited poorer overall survival (P = 0.016).

Conclusions

FISH performed on cytology preparations is useful for confirmation of cancer diagnosis. The three-probe set, 3+7+8, has potential value for the detection of SCCs in bronchial brushings.
Literature
go back to reference Agarwal M, Brahmanday G, Chmielewski GW, Welsh RJ, Ravikrishnan KP (2010) Age, tumor size, type of surgery, and gender predict survival in early stage (stage I and II) non-small cell lung cancer after surgical resection. Lung Cancer 68(3):398–402PubMedCrossRef Agarwal M, Brahmanday G, Chmielewski GW, Welsh RJ, Ravikrishnan KP (2010) Age, tumor size, type of surgery, and gender predict survival in early stage (stage I and II) non-small cell lung cancer after surgical resection. Lung Cancer 68(3):398–402PubMedCrossRef
go back to reference Aviel-Ronen S, Coe BP, Lau SK, da Cunha Santos G, Zhu CQ, Strumpf D, Jurisica I, Lam WL, Tsao MS (2008) Genomic markers for malignant progression in pulmonary adenocarcinoma with bronchioloalveolar features. Proc Natl Acad Sci U S A 105(29):10155–10160PubMedCrossRef Aviel-Ronen S, Coe BP, Lau SK, da Cunha Santos G, Zhu CQ, Strumpf D, Jurisica I, Lam WL, Tsao MS (2008) Genomic markers for malignant progression in pulmonary adenocarcinoma with bronchioloalveolar features. Proc Natl Acad Sci U S A 105(29):10155–10160PubMedCrossRef
go back to reference Balsara BR, Testa JR (2002) Chromosomal imbalances in human lung cancer. Oncogene 21(45):6877–6883PubMedCrossRef Balsara BR, Testa JR (2002) Chromosomal imbalances in human lung cancer. Oncogene 21(45):6877–6883PubMedCrossRef
go back to reference Barkan GA, Caraway NP, Jiang F, Zaidi TM, Fernandez R, Vaporcyin A, Morice R, Zhou X, Bekele BN, Katz RL (2005) Comparison of molecular abnormalities in bronchial brushings and tumor touch preparations. Cancer 105(1):35–43PubMedCrossRef Barkan GA, Caraway NP, Jiang F, Zaidi TM, Fernandez R, Vaporcyin A, Morice R, Zhou X, Bekele BN, Katz RL (2005) Comparison of molecular abnormalities in bronchial brushings and tumor touch preparations. Cancer 105(1):35–43PubMedCrossRef
go back to reference Berrieman HK, Ashman JN, Cowen ME, Greenman J, Lind MJ, Cawkwell L (2004) Chromosomal analysis of non-small-cell lung cancer by multicolour fluorescent in situ hybridisation. Br J Cancer 90(4):900–905PubMedCrossRef Berrieman HK, Ashman JN, Cowen ME, Greenman J, Lind MJ, Cawkwell L (2004) Chromosomal analysis of non-small-cell lung cancer by multicolour fluorescent in situ hybridisation. Br J Cancer 90(4):900–905PubMedCrossRef
go back to reference Bubendorf L, Muller P, Joos L, Grilli B, Vogel S, Herzog M, Barascud A, Feichter G, Dalquen P, Tamm M (2005) Multitarget FISH analysis in the diagnosis of lung cancer. Am J Clin Pathol 123(4):516–523PubMedCrossRef Bubendorf L, Muller P, Joos L, Grilli B, Vogel S, Herzog M, Barascud A, Feichter G, Dalquen P, Tamm M (2005) Multitarget FISH analysis in the diagnosis of lung cancer. Am J Clin Pathol 123(4):516–523PubMedCrossRef
go back to reference Choma D, Daures JP, Quantin X, Pujol JL (2001) Aneuploidy and prognosis of non-small-cell lung cancer: a meta-analysis of published data. Br J Cancer 85(1):14–22PubMedCrossRef Choma D, Daures JP, Quantin X, Pujol JL (2001) Aneuploidy and prognosis of non-small-cell lung cancer: a meta-analysis of published data. Br J Cancer 85(1):14–22PubMedCrossRef
go back to reference Fan YB, Ye L, Wang TY, Wu GP (2010) Correlation between morphology and human telomerase gene amplification in bronchial brushing cells for the diagnosis of lung cancer. Diagn Cytopathol 38(6):402–406PubMedCrossRef Fan YB, Ye L, Wang TY, Wu GP (2010) Correlation between morphology and human telomerase gene amplification in bronchial brushing cells for the diagnosis of lung cancer. Diagn Cytopathol 38(6):402–406PubMedCrossRef
go back to reference Fox JL, Hsu PH, Legator MS, Morrison LE, Seelig SA (1995) Fluorescence in situ hybridization: powerful molecular tool for cancer prognosis. Clin Chem 41(11):1554–1559PubMed Fox JL, Hsu PH, Legator MS, Morrison LE, Seelig SA (1995) Fluorescence in situ hybridization: powerful molecular tool for cancer prognosis. Clin Chem 41(11):1554–1559PubMed
go back to reference Goeze A, Schluns K, Wolf G, Thasler Z, Petersen S, Petersen I (2002) Chromosomal imbalances of primary and metastatic lung adenocarcinomas. J Pathol 196(1):8–16PubMedCrossRef Goeze A, Schluns K, Wolf G, Thasler Z, Petersen S, Petersen I (2002) Chromosomal imbalances of primary and metastatic lung adenocarcinomas. J Pathol 196(1):8–16PubMedCrossRef
go back to reference Halling KC, Kipp BR (2007) Fluorescence in situ hybridization in diagnostic cytology. Hum Pathol 38(8):1137–1144PubMedCrossRef Halling KC, Kipp BR (2007) Fluorescence in situ hybridization in diagnostic cytology. Hum Pathol 38(8):1137–1144PubMedCrossRef
go back to reference Halling KC, Rickman OB, Kipp BR, Harwood AR, Doerr CH, Jett JR (2006) A comparison of cytology and fluorescence in situ hybridization for the detection of lung cancer in bronchoscopic specimens. Chest 130(3):694–701PubMedCrossRef Halling KC, Rickman OB, Kipp BR, Harwood AR, Doerr CH, Jett JR (2006) A comparison of cytology and fluorescence in situ hybridization for the detection of lung cancer in bronchoscopic specimens. Chest 130(3):694–701PubMedCrossRef
go back to reference Li R, Liu Z, Fan T, Jiang F (2006) A novel multiple FISH array for the detection of genetic aberrations in cancer. Lab Invest 86(6):619–627PubMed Li R, Liu Z, Fan T, Jiang F (2006) A novel multiple FISH array for the detection of genetic aberrations in cancer. Lab Invest 86(6):619–627PubMed
go back to reference Lockwood WW, Chari R, Coe BP, Girard L, Macaulay C, Lam S, Gazdar AF, Minna JD, Lam WL (2008) DNA amplification is a ubiquitous mechanism of oncogene activation in lung and other cancers. Oncogene 27(33):4615–4624PubMedCrossRef Lockwood WW, Chari R, Coe BP, Girard L, Macaulay C, Lam S, Gazdar AF, Minna JD, Lam WL (2008) DNA amplification is a ubiquitous mechanism of oncogene activation in lung and other cancers. Oncogene 27(33):4615–4624PubMedCrossRef
go back to reference Mazzone P, Jain P, Arroliga AC, Matthay RA (2002) Bronchoscopy and needle biopsy techniques for diagnosis and staging of lung cancer. Clin Chest Med 23(1):137–158PubMedCrossRef Mazzone P, Jain P, Arroliga AC, Matthay RA (2002) Bronchoscopy and needle biopsy techniques for diagnosis and staging of lung cancer. Clin Chest Med 23(1):137–158PubMedCrossRef
go back to reference Nakamura H, Aute I, Kawasaki N, Taguchi M, Ohira T, Kato H (2005) Quantitative detection of lung cancer cells by fluorescence in situ hybridization: comparison with conventional cytology. Chest 128(2):906–911PubMedCrossRef Nakamura H, Aute I, Kawasaki N, Taguchi M, Ohira T, Kato H (2005) Quantitative detection of lung cancer cells by fluorescence in situ hybridization: comparison with conventional cytology. Chest 128(2):906–911PubMedCrossRef
go back to reference Panani AD, Roussos C (2006) Cytogenetic and molecular aspects of lung cancer. Cancer Lett 239(1):1–9PubMedCrossRef Panani AD, Roussos C (2006) Cytogenetic and molecular aspects of lung cancer. Cancer Lett 239(1):1–9PubMedCrossRef
go back to reference Petersen I (2011) The morphological and molecular diagnosis of lung cancer. Dtsch Arztebl Int 108(31–32):525–531PubMed Petersen I (2011) The morphological and molecular diagnosis of lung cancer. Dtsch Arztebl Int 108(31–32):525–531PubMed
go back to reference Petersen I, Bujard M, Petersen S, Wolf G, Goeze A, Schwendel A, Langreck H, Gellert K, Reichel M, Just K, du Manoir S, Cremer T, Dietel M, Ried T (1997a) Patterns of chromosomal imbalances in adenocarcinoma and squamous cell carcinoma of the lung. Cancer Res 57(12):2331–2335PubMed Petersen I, Bujard M, Petersen S, Wolf G, Goeze A, Schwendel A, Langreck H, Gellert K, Reichel M, Just K, du Manoir S, Cremer T, Dietel M, Ried T (1997a) Patterns of chromosomal imbalances in adenocarcinoma and squamous cell carcinoma of the lung. Cancer Res 57(12):2331–2335PubMed
go back to reference Petersen I, Langreck H, Wolf G, Schwendel A, Psille R, Vogt P, Reichel MB, Ried T, Dietel M (1997b) Small-cell lung cancer is characterized by a high incidence of deletions on chromosomes 3p, 4q, 5q, 10q, 13q and 17p. Br J Cancer 75(1):79–86PubMedCrossRef Petersen I, Langreck H, Wolf G, Schwendel A, Psille R, Vogt P, Reichel MB, Ried T, Dietel M (1997b) Small-cell lung cancer is characterized by a high incidence of deletions on chromosomes 3p, 4q, 5q, 10q, 13q and 17p. Br J Cancer 75(1):79–86PubMedCrossRef
go back to reference Petersen S, Aninat-Meyer M, Schluns K, Gellert K, Dietel M, Petersen I (2000) Chromosomal alterations in the clonal evolution to the metastatic stage of squamous cell carcinomas of the lung. Br J Cancer 82(1):65–73PubMedCrossRef Petersen S, Aninat-Meyer M, Schluns K, Gellert K, Dietel M, Petersen I (2000) Chromosomal alterations in the clonal evolution to the metastatic stage of squamous cell carcinomas of the lung. Br J Cancer 82(1):65–73PubMedCrossRef
go back to reference Ried T, Petersen I, Holtgreve-Grez H, Speicher MR, Schrock E, du Manoir S, Cremer T (1994) Mapping of multiple DNA gains and losses in primary small cell lung carcinomas by comparative genomic hybridization. Cancer Res 54(7):1801–1806PubMed Ried T, Petersen I, Holtgreve-Grez H, Speicher MR, Schrock E, du Manoir S, Cremer T (1994) Mapping of multiple DNA gains and losses in primary small cell lung carcinomas by comparative genomic hybridization. Cancer Res 54(7):1801–1806PubMed
go back to reference Savic S, Glatz K, Schoenegg R, Spieler P, Feichter G, Tamm M, Bubendorf L (2006) Multitarget fluorescence in situ hybridization elucidates equivocal lung cytology. Chest 129(6):1629–1635PubMedCrossRef Savic S, Glatz K, Schoenegg R, Spieler P, Feichter G, Tamm M, Bubendorf L (2006) Multitarget fluorescence in situ hybridization elucidates equivocal lung cytology. Chest 129(6):1629–1635PubMedCrossRef
go back to reference Siegel R, Ward E, Brawley O, Jemal A (2011) Cancer statistics, 2011: the impact of eliminating socioeconomic and racial disparities on premature cancer deaths. CA Cancer J Clin 61(4):212–236PubMedCrossRef Siegel R, Ward E, Brawley O, Jemal A (2011) Cancer statistics, 2011: the impact of eliminating socioeconomic and racial disparities on premature cancer deaths. CA Cancer J Clin 61(4):212–236PubMedCrossRef
go back to reference Sokolova IA, Bubendorf L, O’Hare A, Legator MS, Jacobson KK, Grilli BSB, Dalquen P, Halling KC, Tamm M, Seelig SA, Morrison LE (2002) A fluorescence in situ hybridization-based assay for improved detection of lung cancer cells in bronchial washing specimens. Cancer 96(5):306–315PubMedCrossRef Sokolova IA, Bubendorf L, O’Hare A, Legator MS, Jacobson KK, Grilli BSB, Dalquen P, Halling KC, Tamm M, Seelig SA, Morrison LE (2002) A fluorescence in situ hybridization-based assay for improved detection of lung cancer cells in bronchial washing specimens. Cancer 96(5):306–315PubMedCrossRef
go back to reference Tonon G, Wong KK, Maulik G, Brennan C, Feng B, Zhang Y, Khatry DB, Protopopov A, You MJ, Aguirre AJ, Martin ES, Yang Z, Ji H, Chin L, Depinho RA (2005) High-resolution genomic profiles of human lung cancer. Proc Natl Acad Sci U S A 102(27):9625–9630PubMedCrossRef Tonon G, Wong KK, Maulik G, Brennan C, Feng B, Zhang Y, Khatry DB, Protopopov A, You MJ, Aguirre AJ, Martin ES, Yang Z, Ji H, Chin L, Depinho RA (2005) High-resolution genomic profiles of human lung cancer. Proc Natl Acad Sci U S A 102(27):9625–9630PubMedCrossRef
go back to reference Varella-Garcia M, Kittelson J, Schulte AP, Vu KO, Wolf HJ, Zeng C, Hirsch FR, Byers T, Kennedy T, Miller YE, Keith RL, Franklin WA (2004) Multi-target interphase fluorescence in situ hybridization assay increases sensitivity of sputum cytology as a predictor of lung cancer. Cancer Detect Prev 28(4):244–251PubMedCrossRef Varella-Garcia M, Kittelson J, Schulte AP, Vu KO, Wolf HJ, Zeng C, Hirsch FR, Byers T, Kennedy T, Miller YE, Keith RL, Franklin WA (2004) Multi-target interphase fluorescence in situ hybridization assay increases sensitivity of sputum cytology as a predictor of lung cancer. Cancer Detect Prev 28(4):244–251PubMedCrossRef
go back to reference Varella-Garcia M, Chen L, Powell RL, Hirsch FR, Kennedy TC, Keith R, Miller YE, Mitchell JD, Franklin WA (2007) Spectral karyotyping detects chromosome damage in bronchial cells of smokers and patients with cancer. Am J Respir Crit Care Med 176(5):505–512PubMedCrossRef Varella-Garcia M, Chen L, Powell RL, Hirsch FR, Kennedy TC, Keith R, Miller YE, Mitchell JD, Franklin WA (2007) Spectral karyotyping detects chromosome damage in bronchial cells of smokers and patients with cancer. Am J Respir Crit Care Med 176(5):505–512PubMedCrossRef
go back to reference Yendamuri S, Vaporciyan AA, Zaidi T, Feng L, Fernandez R, Bekele NB, Hofstetter WL, Jiang F, Mehran RJ, Rice DC, Spitz MR, Swisher SG, Walsh GL, Roth JA, Katz RL (2008) 3p22.1 and 10q22.3 deletions detected by fluorescence in situ hybridization (FISH): a potential new tool for early detection of non-small cell lung Cancer (NSCLC). J Thorac Oncol 3(9):979–984PubMedCrossRef Yendamuri S, Vaporciyan AA, Zaidi T, Feng L, Fernandez R, Bekele NB, Hofstetter WL, Jiang F, Mehran RJ, Rice DC, Spitz MR, Swisher SG, Walsh GL, Roth JA, Katz RL (2008) 3p22.1 and 10q22.3 deletions detected by fluorescence in situ hybridization (FISH): a potential new tool for early detection of non-small cell lung Cancer (NSCLC). J Thorac Oncol 3(9):979–984PubMedCrossRef
Metadata
Title
A potential probe set of fluorescence in situ hybridization for detection of lung cancer in bronchial brushing specimens
Authors
Yi-Zhen Liu
Zhen Wang
Li-Li Fang
Lu Li
Jian Cao
Xin Xu
Ya-Ling Han
Yan Cai
Liang-Xu Wang
Ming-Rong Wang
Publication date
01-09-2012
Publisher
Springer-Verlag
Published in
Journal of Cancer Research and Clinical Oncology / Issue 9/2012
Print ISSN: 0171-5216
Electronic ISSN: 1432-1335
DOI
https://doi.org/10.1007/s00432-012-1232-0

Other articles of this Issue 9/2012

Journal of Cancer Research and Clinical Oncology 9/2012 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.